Enhancement of D1 dopamine receptor-mediated locomotor stimulation in M4 muscarinic acetylcholine receptor knockout mice

Proceedings of the National Academy of Sciences of the United States of America

Volumn 96, Issue 18, 1999, Pages 10483-10488

  Gomeza, Jesus ^a   Zhang, Lu ^b   Kostenis, Evi ^a   Felder, Christian ^b   Bymaster, Frank ^b   Brodkin, Jesse ^b   Shannon, Harlan ^b   Xia, Bing ^a   Deng, Chu Xia ^a   Wess, Jürgen ^a  

^a NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^b ELI LILLY AND COMPANY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3,4 DIHYDROXYPHENYLACETIC ACID; ACETYLCHOLINE; DOPAMINE; DOPAMINE 1 RECEPTOR; MUSCARINIC M4 RECEPTOR; RECEPTOR SUBTYPE;

ANALGESIA; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; FOREBRAIN; GENE TARGETING; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HYPOTHERMIA; IMMUNOPRECIPITATION; LOCOMOTION; MOUSE; NEUROTRANSMISSION; NONHUMAN; PRIORITY JOURNAL; SALIVATION; TREMOR;

2,3,4,5-TETRAHYDRO-7,8-DIHYDROXY-1-PHENYL-1H-3-BENZAZEPINE; ANALGESIA; ANIMALS; APOMORPHINE; BRAIN; CORPUS STRIATUM; DOPAMINE AGONISTS; HYPOTHERMIA; MICE; MICE, KNOCKOUT; MOTOR ACTIVITY; OXOTREMORINE; PROSENCEPHALON; QUINPIROLE; RADIOLIGAND ASSAY; RECEPTOR, MUSCARINIC M4; RECEPTORS, DOPAMINE D1; RECEPTORS, MUSCARINIC; SALIVATION; TREMOR;

ANIMALIA;

EID: 13044283415     PISSN: 00278424     EISSN: None     Source Type: Journal    
DOI: 10.1073/pnas.96.18.10483     Document Type: Article

References (41)

1. Levine, R. R. & Birdsall, N. J. M., eds. (1995) Life Sci. 56, 801-1050.
2. Brown, J. H. & Taylor, P. (1996) in The Pharmacological Basis of Therapeutics, eds. Hardman, J. G. & Limbird, L. E. (McGraw-Hill, New York), 9th Ed., pp. 141-160.
3. Levine, R. R. & Birdsall, N. J. M., eds. (1997) Life Sci. 60, 963-1207.
4. Levey, A. I. (1993) Life Sci. 52, 441-448.
5. Vilaro, M. T., Mengod, G. & Palacios, J. M. (1993) Prog. Brain Res. 98, 95-101.
6. Wolfe, B. B. & Yasuda, R. P. (1995) Ann. N. Y. Acad. Sci. 757, 186-193.
7. Levey, A. I., Kitt, C. A., Simonds, W. F., Price, D. L. & Brann, M. R. (1991) J. Neurosci. 11, 3218-3226.
8. Caulfield, M. P. (1993) Pharmacol. Ther. 58, 319-379.
9. Wess, J. (1996) Crit. Rev. Neurobiol. 10, 69-99.
10. Yasuda, R. P., Ciesla, W., Flores, L. R., Wall, S. J., Li, M., Satkus, S. A., Weisstein, J. S., Spagnola, B. V. & Wolfe, B. B. (1993) Mol. Pharmacol. 43, 149-157.
11. Hersch, S. M., Gutekunst, C.-A., Rees, H. D., Heilman, C. J. & Levey, A. I. (1994) J. Neurosci. 14, 3351-3363.
12. Gerfen, C. R., Engber, T. M., Mahan, L. C., Susel, Z., Chase, T. N., Monsma, F. J., Jr., & Sibley, D. R. (1990) Science 250, 1429-1432.
13. Weiner, D. M., Levey, A. I. & Brann, M. R. (1990) Proc. Natl. Acad. Sci. USA 87, 7050-7054.
14. Le Moine, C., Normand, E., Guitteny, A. F., Fouque, B., Teoule, R. & Bloch, B. (1990) Proc. Natl. Acad. Sci. USA 87, 230-234.
15. Le Moine, C., Normand, E. & Bloch, B. (1991) Proc. Natl. Acad. Sci. USA 88, 4205-4209.
16. Bernard, V., Normand, E. & Bloch, B. (1992) J. Neurosci. 12, 3591-3600.
17. Hornykiewicz, O. (1981) in Movement Disorders, eds. Marsden, D. C. & Fahn, S. (Butterworth, Boston), pp. 41-58.
18. Di Chiara, G., Morelli, M. & Consolo, S. (1994) Trends Neurosci. 17, 228-233.
19. Shannon, H. E., Womer, D. E., Bymaster, F. P., Calligaro, D. O., Delapp, N. W., Mitch, C. H., Ward, J. S., Whitesitt, C. A., Swedberg, M. D., Sheardown, M. J., et al. (1997) Life Sci. 60, 969-976.
20. Ellis, J. L., Harman, D., Gonzalez, J., Spera, M. L., Liu, R., Shen, T. Y., Wypij, D. M. & Zuo, F. (1999) J. Pharmacol. Exp. Ther. 288, 1143-1150.
21. Gomeza, J., Shannon, H., Kostenis, E., Felder, C., Zhang, L., Brodkin, J., Grinberg, A., Sheng, H. & Wess, J. (1999) Proc. Natl. Acad. Sci. USA 96, 1692-1697.
22. Paszty, C., Mohandas, N., Stevens, M. E., Loring, J. F., Liebhaber, S. A., Brion, C. M. & Rubin, E. M. (1995) Nat. Genet. 11, 33-39.
23. Deng, C., Wynshaw-Boris, A., Zhou, F., Kuo, A. & Leder, P. (1996) Cell 84, 911-921.
24. Gerfen, C. R., Keefe, K. A. & Gauda, E. B. (1995) J. Neurosci. 15, 8167-8176.
25. Dörje, F., Wess, J., Lambrecht, G., Tacke, R., Mutschler, E. & Brann, M. R. (1991) J. Pharmacol. Exp. Ther. 256, 727-733.
26. Farrell, C. B., Lawlor, M., Dunne, A. & O'Boyle K. M. (1995) J. Neurochem. 65, 1124-1130.
27. Sacaan, A. I., Bymaster, F. P. & Schoepp, D. D. (1992) J. Neurochem. 59, 245-251.
28. Starr, B. S. & Starr, M. S. (1986) Neuropharmacology 25, 455-463.
29. Cabib, S., Castellano, C., Cestari, V., Filibeck, U. & Puglisi-Allegra, S. (1991) Psychopharmacology 105, 335-339.
30. Xu, M., Moratalla, R., Gold, L. H., Hiroi, N., Koob, G. F., Graybiel, A. M. & Tonegawa, S. (1994) Cell 79, 729-742.
31. Yaksh, T. L., Dirksen, R. & Harty, G. J. (1985) Eur. J. Pharmacol. 117, 81-88.
32. Green, P. G. & Kitchen, I. (1986) Prog. Neurobiol. 26, 119-146.
33. Hartvig, P., Gillberg, P. G., Gordh, T., Jr., & Post, C. (1989) Trends Pharmacol. Sci. 10, Suppl., 75-79.
34. Iwamoto, E. T. & Marion, L. (1993) J. Pharmacol. Exp. Ther. 266, 329-338.
35. Swedberg, M. D., Sheardown, M. J., Sauerberg, P., Olesen, P. H., Suzdak, P. D., Hansen, K. T., Bymaster, F. P., Ward, J. S., Mitch, C. H., Calligaro, D. O., et al. (1997) J. Pharmacol. Exp. Ther. 281, 876-883.
36. Hamilton, S. E., Loose, M. D., Qi, M., Levey, A. I., Hille, B., McKnight, G. S., Idzerda, R. L. & Nathanson, N. M. (1997) Proc. Natl. Acad. Sci. USA 94, 13311-13316.
37. Sibley, D. R. & Monsma, F. J., Jr. (1992) Trends Pharmacol. Sci. 13, 61-69.
38. Olianas, M. C., Adem, A., Karlsson, E. & Onali, P. (1996) Br. J. Pharmacol. 118, 283-288.
39. Olianas, M. C. & Onali, P. (1996) Br. J. Pharmacol. 118, 827-828.
40. Gerlai, R. (1996) Trends Neurosci. 19, 177-181.
41. Kelly, M. A., Rubinstein, M., Phillips, T. J., Lessov, C. N., Burkhart-Kasch, S., Zhang, G., Bunzow, J. R., Fang, Y., Gerhardt, G. A., Grandy, D. K. & Low, M. J. (1998) J. Neurosci. 18, 3470-3479.